This latter finding was further supported by results in melanoma and breast cancer mouse models, which showed that TGF-β affects the generation of the CXCR3 ligand CCL9 in MDSCs, leading to less immune cell accumulation and cancer cell survival (149). This evidence concerns the gene TGFB1 and melanoma.